- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT07708454
Outcomes After First-line Treatment of Hand Osteoarthritis
Changes in Patient-reported Outcomes After a 3-month First-line Treatment Program in Men and Women With Hand Osteoarthritis
Studieoversikt
Status
Forhold
Intervensjon / Behandling
Detaljert beskrivelse
According to international guidelines, exercise, education and splinting (if needed) should constitute first-line treatment for people with hand osteoarthritis (OA). However, few studies have investigated the outcomes of such treatment in individuals with hand OA. In this retrospective register-based study the investigators will investigate the outcomes of 3-months participation of first-line treatment for hand OA using data from the Swedish Osteoarthritis register (SOAR). Outcomes will be self-reported change in pain, pain frequency, health-related quality of life, physical activity, fear of movement and willingness for joint surgery between baseline and three months follow-up. In addition, the investigators will investigate if potential improvements remain at 12 months.
Statistical analysis Changes in continuous variables between baseline and the two follow-ups (3 and 12 months) will be analyzed using paired T-test. Changes in proportions in the categorical variables will be analyzed using McNemars test for pairwise comparisons. Standardized effect sizes will be reported as Cohen's d with the following cut offs: 0.2=small, 0.5=medium and 0.8=large effect size. All outcomes will be analyzed separately for females and males.
In this study the investigators will include all participants registered in SOAR fulfilling the eligibility criteria outlined below (n>1000) and consequently no power calculation was performed.
Studietype
Registrering (Faktiske)
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
- Barn
- Voksen
- Eldre voksen
Tar imot friske frivillige
Prøvetakingsmetode
Studiepopulasjon
Beskrivelse
Inclusion Criteria:
- a clinical diagnosis of hand OA
- participated for three months in the program
- reported any of the included outcomes at both baseline and at 3 months follow-up.
Studieplan
Hvordan er studiet utformet?
Designdetaljer
Kohorter og intervensjoner
Gruppe / Kohort |
Intervensjon / Behandling |
|---|---|
|
Hand osteoarthritis
Patients with a clinical diagnosis of hand osteoarthritis participating in a first-line treatment program
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
NRS pain
Tidsramme: From enrollment to 3 and 12 months follow-up, respectively
|
The NRS comprises an 11-point scale where 0 indicates no pain and 10 indicates the worst possible pain.
|
From enrollment to 3 and 12 months follow-up, respectively
|
|
Health-related quality of life
Tidsramme: From enrollment to 3 and 12 months, respectively
|
Assessed with the EuroQol - 5 dimension descriptive system (EQ-5D-3L)
|
From enrollment to 3 and 12 months, respectively
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Pain frequency
Tidsramme: From enrollment to 3 and 12 months follow-up, respectively
|
dichotomous, frequent/rare
|
From enrollment to 3 and 12 months follow-up, respectively
|
|
Physical activity
Tidsramme: From enrollment to 3 and 12 months follow-up, respectively
|
Assessed with the Swedish Board of Health and Welfare indicators
|
From enrollment to 3 and 12 months follow-up, respectively
|
|
Fear of movement
Tidsramme: from enrollment to 3 and 12 months follow-up, respectively
|
Dichotomous reply, yes/no
|
from enrollment to 3 and 12 months follow-up, respectively
|
|
Willingness for surgery
Tidsramme: From enrollment to 3 and 12 months follow-up, respectively
|
Dichotomous reply, yes/no
|
From enrollment to 3 and 12 months follow-up, respectively
|
Samarbeidspartnere og etterforskere
Sponsor
Etterforskere
- Hovedetterforsker: Anna Cronström, PhD, Lund University
Studierekorddatoer
Studer hoveddatoer
Studiestart (Faktiske)
Primær fullføring (Faktiske)
Studiet fullført (Faktiske)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Faktiske)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Nøkkelord
Ytterligere relevante MeSH-vilkår
- Muskel- og skjelettsykdommer
- Leddgikt
- Leddsykdommer
- Revmatiske sykdommer
- Oppførsel
- Artrose
- Motorisk aktivitet
- Motorisk aktivitet
- Bevegelse
- Muskel- og skjelettfysiologiske fenomener
- Muskel- og skjelett og nevrale fysiologiske fenomener
- Sosioøkonomiske faktorer
- Befolkningskarakteristikker
- Øvelse
- Utdanningsstatus
Andre studie-ID-numre
- Dnr: 2022-06657-01
Plan for individuelle deltakerdata (IPD)
Planlegger du å dele individuelle deltakerdata (IPD)?
IPD-planbeskrivelse
Tilgangskriterier for IPD-deling
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Studerer et amerikansk FDA-regulert enhetsprodukt
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .